DESCRIPTION (provided by applicant): The long term objective of this project is to develop validated, genotype-based biomarkers to aid in more accurate diagnosis of schizophrenia and related schizophrenia spectrum disorders, including bipolar disorder. SureGene, LLC is developing two novel genetic…
More